Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 21% ± 3% |
Insufficient scRNA-seq data for expression of ESRP2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 3372.30 | 328 / 328 | 94% | 30.46 | 168 / 178 |
liver | 100% | 5235.51 | 226 / 226 | 94% | 26.46 | 383 / 406 |
thymus | 100% | 4838.46 | 651 / 653 | 94% | 25.63 | 570 / 605 |
prostate | 88% | 3162.20 | 216 / 245 | 100% | 55.68 | 501 / 502 |
lung | 89% | 2149.29 | 513 / 578 | 98% | 42.03 | 1130 / 1155 |
stomach | 75% | 3590.61 | 269 / 359 | 97% | 41.58 | 277 / 286 |
breast | 57% | 1468.89 | 262 / 459 | 99% | 40.02 | 1107 / 1118 |
kidney | 100% | 2220.99 | 89 / 89 | 54% | 7.91 | 490 / 901 |
bladder | 48% | 1402.76 | 10 / 21 | 96% | 53.66 | 485 / 504 |
intestine | 43% | 1851.19 | 420 / 966 | 98% | 43.63 | 518 / 527 |
esophagus | 38% | 4281.27 | 555 / 1445 | 99% | 55.71 | 181 / 183 |
tonsil | 0% | 0 | 0 / 0 | 100% | 40.02 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 61.96 | 1 / 1 |
ovary | 0% | 0 | 0 / 180 | 94% | 21.76 | 405 / 430 |
uterus | 6% | 129.11 | 11 / 170 | 86% | 37.74 | 393 / 459 |
skin | 72% | 4407.88 | 1305 / 1809 | 6% | 1.29 | 28 / 472 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.30 | 1 / 29 |
adipose | 1% | 14.42 | 12 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0 | 0 / 258 | 0% | 0.05 | 1 / 230 |
spleen | 0% | 6.83 | 1 / 241 | 0% | 0 | 0 / 0 |
muscle | 0% | 2.03 | 2 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 2.19 | 2 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.99 | 1 / 929 | 0% | 0 | 0 / 0 |
brain | 0% | 0.23 | 1 / 2642 | 0% | 0 | 0 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0050673 | Biological process | epithelial cell proliferation |
GO_0043484 | Biological process | regulation of RNA splicing |
GO_0060441 | Biological process | epithelial tube branching involved in lung morphogenesis |
GO_0050679 | Biological process | positive regulation of epithelial cell proliferation |
GO_0060445 | Biological process | branching involved in salivary gland morphogenesis |
GO_0000380 | Biological process | alternative mRNA splicing, via spliceosome |
GO_0005634 | Cellular component | nucleus |
GO_0005654 | Cellular component | nucleoplasm |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0005515 | Molecular function | protein binding |
GO_0003729 | Molecular function | mRNA binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | ESRP2 |
Protein name | Epithelial splicing regulatory protein 2 (RNA-binding motif protein 35B) (RNA-binding protein 35B) Epithelial splicing regulatory protein 2 |
Synonyms | RBM35B PP7059 |
Description | FUNCTION: mRNA splicing factor that regulates the formation of epithelial cell-specific isoforms. Specifically regulates the expression of FGFR2-IIIb, an epithelial cell-specific isoform of FGFR2. Also regulates the splicing of CD44, CTNND1, ENAH, 3 transcripts that undergo changes in splicing during the epithelial-to-mesenchymal transition (EMT). Acts by directly binding specific sequences in mRNAs. Binds the GU-rich sequence motifs in the ISE/ISS-3, a cis-element regulatory region present in the mRNA of FGFR2. . |
Accessions | ENST00000566774.1 A0A0A1TTP8 J3QKU3 J3QQJ9 ENST00000565858.5 [Q9H6T0-1] A0A0A1TE42 ENST00000564382.5 Q9H6T0 J3KRF2 ENST00000473183.7 [Q9H6T0-2] ENST00000562724.1 |